Parallax Volatility Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.65M | Buy |
4,790
+4,788
| +239,400% | +$1.71M | ﹤0.01% | 837 |
|
|
2025
Q4 | $655 | Sell |
2
-7,512
| -100% | -$2.38M | ﹤0.01% | 1584 |
|
|
2025
Q3 | $2.12M | Buy |
7,514
+4,421
| +143% | +$1.28M | ﹤0.01% | 905 |
|
|
2025
Q2 | $864K | Buy |
3,093
+3,090
| +103,000% | +$875K | ﹤0.01% | 1091 |
|
|
2025
Q1 | $935 | Sell |
3
-36,019
| -100% | -$10.6M | ﹤0.01% | 1457 |
|
|
2024
Q4 | $9.39M | Buy |
+36,022
| New | +$10.7M | 0.02% | 590 |
|
|
2024
Q2 | – | Sell |
-19,595
| Closed | -$5.76M | – | 1973 |
|
|
2024
Q1 | $5.57M | Buy |
19,595
+4,938
| +34% | +$1.44M | 0.01% | 699 |
|
|
2023
Q4 | $4.22M | Sell |
14,657
-8,998
| -38% | -$2.45M | 0.01% | 885 |
|
|
2023
Q3 | $6.36M | Buy |
23,655
+23,625
| +78,750% | +$5.9M | 0.01% | 680 |
|
|
2023
Q2 | $6.66K | Hold |
30
| – | – | ﹤0.01% | 2206 |
|
|
2023
Q1 | $7.25K | Sell |
30
-30
| -50% | -$7.36K | ﹤0.01% | 2438 |
|
|
2022
Q4 | $15.8K | Sell |
60
-58,867
| -100% | -$15.8M | ﹤0.01% | 2510 |
|
|
2022
Q3 | $13.3M | Buy |
+58,927
| New | +$14.3M | 0.02% | 664 |
|
|
2020
Q4 | – | Sell |
-363
| Closed | -$92K | – | 2287 |
|
|
2020
Q3 | $92K | Sell |
363
-6,780
| -95% | -$1.68M | ﹤0.01% | 2735 |
|
|
2020
Q2 | $1.69M | Sell |
7,143
-79,707
| -92% | -$18.2M | ﹤0.01% | 1535 |
|
|
2020
Q1 | $17.6M | Sell |
86,850
-67,080
| -44% | -$14.7M | 0.02% | 436 |
|
|
2019
Q4 | $37.1M | Buy |
153,930
+6,016
| +4% | +$1.33M | 0.04% | 268 |
|
|
2019
Q3 | $28.6M | Buy |
147,914
+146,241
| +8,741% | +$28.1M | 0.03% | 291 |
|
|
2019
Q2 | $308K | Sell |
1,673
-47,218
| -97% | -$8.45M | ﹤0.01% | 1630 |
|
|
2019
Q1 | $9.29M | Sell |
48,891
-59,972
| -55% | -$11.5M | 0.01% | 503 |
|
|
2018
Q4 | $21.2M | Buy |
+108,863
| New | +$21.2M | 0.03% | 330 |
|
|
2018
Q3 | – | Sell |
-11,894
| Closed | -$2.34M | – | 2538 |
|
|
2018
Q2 | $2.2M | Buy |
+11,894
| New | +$2.1M | ﹤0.01% | 871 |
|
|
2018
Q1 | – | Sell |
-17,290
| Closed | -$3.17M | – | 2198 |
|
|
2017
Q4 | $3.01M | Buy |
+17,290
| New | +$3.06M | ﹤0.01% | 781 |
|
|
2017
Q1 | – | Sell |
-12,961
| Closed | -$2.15M | – | 3501 |
|
|
2016
Q4 | $1.9M | Buy |
+12,961
| New | +$1.95M | ﹤0.01% | 990 |
|
|
2016
Q2 | – | Sell |
-3,794
| Closed | -$590K | – | 2478 |
|
|
2016
Q1 | $569K | Sell |
3,794
-48,586
| -93% | -$7.22M | ﹤0.01% | 1408 |
|
|
2015
Q4 | $8.5M | Buy |
52,380
+8,172
| +18% | +$1.28M | 0.02% | 508 |
|
|
2015
Q3 | $6.12M | Sell |
44,208
-48,709
| -52% | -$7.68M | 0.01% | 618 |
|
|
2015
Q2 | $14.3M | Buy |
92,917
+37,799
| +69% | +$6.06M | 0.03% | 374 |
|
|
2015
Q1 | $8.81M | Sell |
55,118
-101,277
| -65% | -$16M | 0.02% | 510 |
|
|
2014
Q4 | $24.9M | Buy |
156,395
+30,246
| +24% | +$4.71M | 0.07% | 254 |
|
|
2014
Q3 | $17.7M | Buy |
126,149
+125,964
| +68,089% | +$16.4M | 0.06% | 292 |
|
|
2014
Q2 | $22K | Sell |
185
-38,805
| -100% | -$4.49M | ﹤0.01% | 3427 |
|
|
2014
Q1 | $4.81M | Buy |
+38,990
| New | +$4.73M | 0.03% | 402 |
|
Other funds holding AMGN
VCM
VPM
Parallax Volatility Advisers's AMGN Position: Q1 2026 in Review
Parallax Volatility Advisers increased its Amgen (AMGN) stake by 239,400% in Q1 2026, buying an estimated $1.71M and bringing the position to 4,790 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #837.
Parallax Volatility Advisers first reported a position in AMGN in Q1 2014 and has held it in 33 quarters since. The position peaked at $37.1M in Q4 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Parallax Volatility Advisers held 4,790 shares of Amgen worth $1.65M as of Q1 2026.
- Parallax Volatility Advisers bought 4,788 Amgen shares in Q1 2026, an estimated $1.71M.
- Amgen made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #837 holding.
- Parallax Volatility Advisers first reported a position in Amgen in Q1 2014 and has held it in 33 quarters since.
- Parallax Volatility Advisers's Amgen position peaked at $37.1M in Q4 2019.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.